FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2099492038> ?p ?o ?g. }

• W2099492038 endingPage "1608" @default.
• W2099492038 startingPage "1601" @default.
• W2099492038 abstract "BACKGROUND To assess the impact of T-cell/B-cell phenotype on clinical outcome, the authors retrospectively compared patients who had peripheral T-cell lymphoma, unspecified (PTCL-U), with patients who had diffuse large B-cell lymphoma (DLBCL). METHODS Two hundred ninety-seven cases of PTCL-U and 496 cases of DLBCL that had been transferred from the files of the Intergruppo Italiano Linfomi or the Gruppo Italiano Linfomi were integrated into a unique working file and reviewed by the authors. RESULTS The PTCL-U group and the DLBCL group had significantly different distribution patterns with respect to patient age, gender, disease stage, performance status (PS), the presence or absence of systemic “B” symptoms, the presence or absence of bulky disease, lactic acid dehydrogenase (LDH) levels, and number of extranodal sites (ENS). A significantly greater number of patients in the DLBCL group experienced complete remission (P < 0.0001). Multinomial logistic regression analysis confirmed that immunophenotype, PS, LDH concentration, and number of ENS were independent predictors of response. At a median follow-up duration of 43 months, there was no observable difference in disease-free survival (DFS) between patients with DLBCL and patients with PTCL-U; however, multivariate analysis did reveal that poorer PS and bone marrow involvement were significantly associated with shorter DFS. Furthermore, although the overall survival (OS) curves associated with the T-cell and B-cell immunophenotypes were significantly different from each other at a median follow-up duration of 37 months (P = 0.0012), Cox multivariate analysis excluded immunophenotype from the final OS model. CONCLUSIONS The findings made in the current study indicate that the natural history of PTCL-U may differ from that of DLBCL. Patients with PTCL-U tended to have less favorable clinical outcomes, although the observed difference in outcome was only partially attributable to immunophenotype, which was independently associated with response, but not with survival. Differences in prognostic factor distributions between patients with PTCL-U and patients with DLBCL may account for some portion of the expected phenotype-associated risk. Cancer 2004. © 2004 American Cancer Society" @default.
• W2099492038 created "2016-06-24" @default.
• W2099492038 creator A5011779828 @default.
• W2099492038 creator A5015840872 @default.
• W2099492038 creator A5020113695 @default.
• W2099492038 creator A5022153283 @default.
• W2099492038 creator A5035398527 @default.
• W2099492038 creator A5046680192 @default.
• W2099492038 creator A5049017377 @default.
• W2099492038 creator A5049158191 @default.
• W2099492038 creator A5057305976 @default.
• W2099492038 creator A5058392949 @default.
• W2099492038 creator A5063805789 @default.
• W2099492038 creator A5064125825 @default.
• W2099492038 date "2004-01-01" @default.
• W2099492038 modified "2023-10-12" @default.
• W2099492038 title "Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas" @default.
• W2099492038 cites W1875404032 @default.
• W2099492038 cites W1895342060 @default.
• W2099492038 cites W1974203122 @default.
• W2099492038 cites W1979327030 @default.
• W2099492038 cites W2019181493 @default.
• W2099492038 cites W2092993480 @default.
• W2099492038 cites W2096393559 @default.
• W2099492038 cites W2097496489 @default.
• W2099492038 cites W2100163251 @default.
• W2099492038 cites W2107202569 @default.
• W2099492038 cites W2129214379 @default.
• W2099492038 cites W2133267160 @default.
• W2099492038 cites W2142599682 @default.
• W2099492038 cites W2160217770 @default.
• W2099492038 cites W2165524473 @default.
• W2099492038 cites W2229704186 @default.
• W2099492038 cites W2253448891 @default.
• W2099492038 cites W2255549241 @default.
• W2099492038 cites W2269332494 @default.
• W2099492038 cites W2314371984 @default.
• W2099492038 cites W2505185289 @default.
• W2099492038 cites W2608724752 @default.
• W2099492038 cites W4205736005 @default.
• W2099492038 cites W4232380993 @default.
• W2099492038 cites W70385801 @default.
• W2099492038 doi "https://doi.org/10.1002/cncr.20531" @default.
• W2099492038 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15378507" @default.
• W2099492038 hasPublicationYear "2004" @default.
• W2099492038 type Work @default.
• W2099492038 sameAs 2099492038 @default.
• W2099492038 citedByCount "40" @default.
• W2099492038 countsByYear W20994920382012 @default.
• W2099492038 countsByYear W20994920382013 @default.
• W2099492038 countsByYear W20994920382014 @default.
• W2099492038 countsByYear W20994920382015 @default.
• W2099492038 countsByYear W20994920382016 @default.
• W2099492038 countsByYear W20994920382017 @default.
• W2099492038 countsByYear W20994920382018 @default.
• W2099492038 crossrefType "journal-article" @default.
• W2099492038 hasAuthorship W2099492038A5011779828 @default.
• W2099492038 hasAuthorship W2099492038A5015840872 @default.
• W2099492038 hasAuthorship W2099492038A5020113695 @default.
• W2099492038 hasAuthorship W2099492038A5022153283 @default.
• W2099492038 hasAuthorship W2099492038A5035398527 @default.
• W2099492038 hasAuthorship W2099492038A5046680192 @default.
• W2099492038 hasAuthorship W2099492038A5049017377 @default.
• W2099492038 hasAuthorship W2099492038A5049158191 @default.
• W2099492038 hasAuthorship W2099492038A5057305976 @default.
• W2099492038 hasAuthorship W2099492038A5058392949 @default.
• W2099492038 hasAuthorship W2099492038A5063805789 @default.
• W2099492038 hasAuthorship W2099492038A5064125825 @default.
• W2099492038 hasBestOaLocation W20994920381 @default.
• W2099492038 hasConcept C126322002 @default.
• W2099492038 hasConcept C142724271 @default.
• W2099492038 hasConcept C143998085 @default.
• W2099492038 hasConcept C147483822 @default.
• W2099492038 hasConcept C196166836 @default.
• W2099492038 hasConcept C203014093 @default.
• W2099492038 hasConcept C2776090121 @default.
• W2099492038 hasConcept C2777891184 @default.
• W2099492038 hasConcept C2778559949 @default.
• W2099492038 hasConcept C2779338263 @default.
• W2099492038 hasConcept C2779714933 @default.
• W2099492038 hasConcept C38180746 @default.
• W2099492038 hasConcept C71924100 @default.
• W2099492038 hasConcept C8891405 @default.
• W2099492038 hasConcept C90924648 @default.
• W2099492038 hasConceptScore W2099492038C126322002 @default.
• W2099492038 hasConceptScore W2099492038C142724271 @default.
• W2099492038 hasConceptScore W2099492038C143998085 @default.
• W2099492038 hasConceptScore W2099492038C147483822 @default.
• W2099492038 hasConceptScore W2099492038C196166836 @default.
• W2099492038 hasConceptScore W2099492038C203014093 @default.
• W2099492038 hasConceptScore W2099492038C2776090121 @default.
• W2099492038 hasConceptScore W2099492038C2777891184 @default.
• W2099492038 hasConceptScore W2099492038C2778559949 @default.
• W2099492038 hasConceptScore W2099492038C2779338263 @default.
• W2099492038 hasConceptScore W2099492038C2779714933 @default.
• W2099492038 hasConceptScore W2099492038C38180746 @default.
• W2099492038 hasConceptScore W2099492038C71924100 @default.
• W2099492038 hasConceptScore W2099492038C8891405 @default.

• next